Investing News Novavax Is Trying to Get the FDA’s Permission to Market COVID-19 Booster Dose August 16, 2022
Investing News Novavax Reports Lower Q2 Revenue and Profit, Reduces Sales Guidance by Half August 9, 2022
Investing News GILEAD SCIENCES, Inc. IMPROVES ITS OUTLOOK FOR 2022 AS ITS HIV AND CANCER CHARTER THRIVE August 3, 2022
Investing News Arcellx Chosen As New Buy At Canaccord Genuity On Multiple Myeloma Shares July 20, 2022